Clough Capital Partners LP decreased Imax Corp (IMAX) stake by 92.07% reported in 2017Q3 SEC filing. Clough Capital Partners LP sold 184,021 shares as Imax Corp (IMAX)’s stock declined 13.83%. The Clough Capital Partners LP holds 15,860 shares with $359,000 value, down from 199,881 last quarter. Imax Corp now has $1.30 billion valuation. The stock decreased 0.25% or $0.05 during the last trading session, reaching $19.95. About 217,840 shares traded. IMAX Corporation (NYSE:IMAX) has declined 15.66% since March 21, 2017 and is downtrending. It has underperformed by 32.36% the S&P500.
Orthopediatrics Corp (NASDAQ:KIDS) had an increase of 11.12% in short interest. KIDS’s SI was 109,900 shares in March as released by FINRA. Its up 11.12% from 98,900 shares previously. With 33,300 avg volume, 3 days are for Orthopediatrics Corp (NASDAQ:KIDS)’s short sellers to cover KIDS’s short positions. The SI to Orthopediatrics Corp’s float is 1.62%. The stock increased 0.57% or $0.1 during the last trading session, reaching $17.71. About 8,402 shares traded. OrthoPediatrics Corp. (NASDAQ:KIDS) has 0.00% since March 21, 2017 and is . It has underperformed by 16.70% the S&P500.
Analysts await IMAX Corporation (NYSE:IMAX) to report earnings on April, 19. IMAX’s profit will be $1.95M for 166.25 P/E if the $0.03 EPS becomes a reality. After $0.22 actual earnings per share reported by IMAX Corporation for the previous quarter, Wall Street now forecasts -86.36% negative EPS growth.
Among 18 analysts covering IMAX (NYSE:IMAX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. IMAX had 62 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was downgraded by Credit Suisse to “Neutral” on Wednesday, February 1. As per Friday, October 16, the company rating was maintained by Dougherty & Company. Canaccord Genuity maintained it with “Buy” rating and $33.0 target in Friday, September 22 report. The rating was reinitiated by JP Morgan with “Overweight” on Tuesday, February 20. The stock of IMAX Corporation (NYSE:IMAX) has “Buy” rating given on Thursday, July 20 by Roth Capital. The firm earned “Buy” rating on Wednesday, September 9 by M Partners. The stock of IMAX Corporation (NYSE:IMAX) earned “Buy” rating by Roth Capital on Tuesday, January 9. Canaccord Genuity maintained it with “Buy” rating and $3300 target in Tuesday, July 18 report. The rating was downgraded by Piper Jaffray to “Hold” on Tuesday, January 9. On Tuesday, February 20 the stock rating was maintained by FBR Capital with “Buy”.